Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is receiving European Commission and French government funds to develop vaccines that prote… https://t.co/Ijt0cLCBd0
    about 7 hours ago
  • New post on Science and Enterprise: EC, France Fund Universal Covid-19, Flu Vaccines https://t.co/qT6cmb5P1S #Science #Business
    about 7 hours ago
  • Plant scientists in California discovered a natural peptide that stops bacteria from causing citrus greening, a dis… https://t.co/S4C9V2nW0p
    about 13 hours ago
  • New post on Science and Enterprise: Univ. Lab Discovers, Licenses Citrus Disease Treatment https://t.co/Hz2YkVgnac #Science #Business
    about 13 hours ago
  • The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines… https://t.co/7P1yBG9iO5
    about 1 day ago

Please share Science & Enterprise

NIH to Fund Development of Organ-On-Chip Devices

Gut-on-a-chip (Wyss Institute, Harvard University)

Gut-on-a-chip (Wyss Institute, Harvard University)

National Institutes of Health will support 17 research initiatives leading to development of microfluidic chips that simulate the structure and function of human organs. NIH’s National Center for Advancing Translational Sciences is funding the projects for five years at a total cost of $70 million.

The project involves collaboration with the Defense Advanced Research Projects Agency and U.S. Food and Drug Administration. The chips are expected to speed safety and efficacy testing of drug candidates, providing an alternative to animal testing that can be time consuming and less reliable.

Tissue chips, as the devices are called, adopt techniques from the computer industry with tissue engineering to create miniature models of living organ tissues on a hand-held transparent microchip. The chips are lined with living cells and contain features designed to replicate the complex biological functions of specific organs, such as heart, lung, and intestine (pictured left).

NIH says more than 30 percent of promising medications have failed when found to be toxic in human clinical trials, despite promising preclinical studies that test the compounds on animals. Tissue chips, which are a newer human cell-based approach, may help researchers better predict how effective a therapeutic candidate would be in clinical studies.

Ten of the 17 awards will support research on cellular microsystems that represent a number of human organs, and that lead to the development of individual microchips. The bio-engineered devices are expected to be functionally relevant and reflect the complexity of the tissue of origin, including genomic diversity, disease complexity, and pharmacological response.

The other seven awards will explore the potential of stem and precursor cells that differentiate into multiple cell types representing the cellular architecture in organ systems. These stem and precursor cells could act as a source of tissue cells to populate the devices.

The following video from the Wyss Institute for Biologically Inspired Engineering at Harvard University, one of the grant recipients, tells more about tissue chips.

Read more:

*     *     *

Please share Science & Enterprise ...

1 comment to NIH to Fund Development of Organ-On-Chip Devices